全球癌症治疗市场 - 市场规模、份额、增长分析：按用途（血癌、肺癌）、治疗方法（化疗、标靶治疗） - 行业预测（2023-2030）

2021年全球癌症治疗药物市场规模为1665亿美元。该市场预测将从2022年的1816.5亿美元增长到2030年的3646.2亿美元。

全球癌症药物市场是医疗保健行业中一个充满活力且快速发展的部分。该市场包括针对不同类型癌症的多种治疗方法，包括化疗、免疫治疗、标靶治疗和放射治疗。随着全球癌症罹患率的增加，该市场的特点是持续的研发努力、创新的新药发现以及精准医疗的进步。这个市场的主要参与企业包括製药公司、生物技术公司和研究机构，他们都在寻求在与癌症的持续斗争中提供更好的治疗选择并改善患者的治疗结果。我正在努力。

全球癌症罹患率上升是癌症治疗市场增长的关键促进因素。高龄化、生活方式的改变和环境暴露等要素导致各种癌症的患病率不断增加，从而对有效治疗方案的需求不断增长。

基因组学、蛋白质组学和分子诊断学的技术进步正在提高我们对癌症生物学的理解。这些知识促进了标靶治疗和个人化医疗的发展，从而改善了治疗结果并减少了副作用。

许多癌症治疗，尤其标靶治疗和免疫治疗，都很昂贵。高昂的治疗费用限制了低收入地区患者的治疗机会，并增加了个人和医疗保健系统的经济负担。

儘管癌症治疗在减少副作用方面取得了长足进步，但某些治疗方法（例如化疗）仍然会引起副作用和毒性。潜在的严重副作用可能会影响治疗期间患者的依从性和生活质量。

随着用于癌症治疗的几种生物製剂的专利到期，生物仿製药的开发和批准正在增加。生物仿製药为昂贵的癌症生物製剂提供了一种经济高效的替代品，并改善了患者获得治疗的机会。

该报告考察了全球癌症治疗市场，并提供了市场概述，包括按用途、治疗、地区和参与市场的公司概况分類的趋势。

目录

执行摘要

市场概况

母市场分析

市场概况

市场规模

• 市场动态
• 促进因素
• 机会
• 抑制因素
• 课题
• SWOT分析

关键市场洞察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 知识产权分析
• 贸易分析
• 启动分析
• 原材料分析
• 创新矩阵
• 管道产品分析
• 宏观经济指标

COVID-19 的影响

市场动态及预测

• 市场动态
• 促进因素
• 机会
• 抑制因素
• 课题
• 法规状况
• SWOT分析
• 波特分析

市场规模及区域

• 北美
• 欧洲
• 亚太地区
• 拉美
• 中东/非洲

主要企业简介

• 竞争形势

Global Cancer Therapeutics Market size was valued at USD 166.5 Billion in 2021 and is poised to grow from USD 181.65 Billion in 2022 to USD 364.62 Billion by 2030,

The Global Cancer Therapeutics Market is a dynamic and rapidly evolving sector within the healthcare industry. It encompasses a wide range of treatments, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, aimed at combating various types of cancer. With increasing cancer incidence worldwide, the market is characterized by constant research and development efforts, innovative drug discoveries, and advancements in precision medicine. Key players in this market include pharmaceutical companies, biotechnology firms, and research institutions, all striving to provide better therapeutic options and improve patient outcomes in the ongoing battle against cancer.

Top-down and bottom-up approaches were used to estimate and validate the size of Cancer Therapeutics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Therapeutics Market Segmental Analysis Report

The global cancer therapeutics market is segmented on the basis of application, therapy, and region. By application, the market is segmented into blood cancer, lung cancer, and other types of cancer. By therapy, the market is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and other treatment modalities. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Cancer Therapeutics Market Dynamics

Driver:

Rising Cancer Prevalence

The increasing incidence of cancer worldwide is a significant driver for the growth of the cancer therapeutics market. Factors such as an aging population, lifestyle changes, and environmental exposures contribute to the higher prevalence of various cancer types, creating a growing demand for effective treatment options.

Advancements in Medical Technology

Technological advancements in genomics, proteomics, and molecular diagnostics have enabled better understanding of cancer biology. This knowledge has led to the development of targeted therapies and personalised medicine, improving treatment outcomes and reducing side effects.

Restraint:

High Cost of Cancer Treatments

Many cancer therapies, especially targeted therapies and immunotherapies, are expensive. The high cost of treatment can limit access for patients in low-income regions and contribute to financial burden, both for individuals and healthcare systems.

Side Effects and Toxicity

While cancer therapies have made significant progress in reducing side effects, some treatments, such as chemotherapy, can still cause adverse reactions and toxicity. The potential for severe side effects may impact patient compliance and quality of life during treatment.

Global Cancer Therapeutics Key Market Trends

Development of Biosimilars: With several biologics used in cancer treatment coming off-patent, there has been an increase in the development and approval of biosimilars. Biosimilars offer cost-effective alternatives to expensive cancer biologics, increasing patient access to treatment.

Personalized Cancer Vaccines: The development of personalised cancer vaccines is a promising area of research. These vaccines are tailored to individual patients based on their tumour's genetic profile, potentially offering a more targeted and effective treatment approach.

Table of Contents

Executive Summary

Market overview

• Exhibit: Executive Summary - Chart on Market Overview
• Exhibit: Executive Summary - Data Table on Market Overview
• Exhibit: Executive Summary - Chart on Global Cancer Therapeutics Market Characteristics
• Exhibit: Executive Summary - Chart on Market by Geography
• Exhibit: Executive Summary - Chart on Market Segmentation
• Exhibit: Executive Summary - Chart on Incremental Growth
• Exhibit: Executive Summary - Data Table on Incremental Growth
• Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

• Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
• Drivers
• Opportunities
• Restraints
• Challenges
• SWOT Analysis

KEY MARKET INSIGHTS

• Technology Analysis
  • (Exhibit: Data Table: Name of technology and details)
• Pricing Analysis
  • (Exhibit: Data Table: Name of technology and pricing details)
• Supply Chain Analysis
  • (Exhibit: Detailed Supply Chain Presentation)
• Value Chain Analysis
  • (Exhibit: Detailed Value Chain Presentation)
• Ecosystem Of the Market
  • Exhibit: Parent Market Ecosystem Market Analysis
  • Exhibit: Market Characteristics of Parent Market
• IP Analysis
  • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
• Trade Analysis
  • (Exhibit: Data Table: Import and Export data details)
• Startup Analysis
  • (Exhibit: Data Table: Emerging startups details)
• Raw Material Analysis
  • (Exhibit: Data Table: Mapping of key raw materials)
• Innovation Matrix
  • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
• Pipeline product Analysis
  • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
• Macroeconomic Indicators

COVID IMPACT

• Introduction
• Impact On Economy-scenario Assessment
  • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
• Revised Market Size
  • Exhibit: Data Table on Global Cancer Therapeutics Market size and forecast 2021-2027 ($ million)
• Impact Of COVID On Key Segments
  • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
• COVID Strategies By Company
  • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

• Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
• Drivers
• Opportunities
• Restraints
• Challenges
• Regulatory Landscape
  • Exhibit: Data Table on regulation from different region
• SWOT Analysis
• Porters Analysis
  • Competitive rivalry
• Exhibit: Competitive rivalry Impact of key factors, 2021
  • Threat of substitute products
• Exhibit: Threat of Substitute Products Impact of key factors, 2021
  • Bargaining power of buyers
• Exhibit: buyers bargaining power Impact of key factors, 2021
  • Threat of new entrants
• Exhibit: Threat of new entrants Impact of key factors, 2021
  • Bargaining power of suppliers
• Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
• Skyquest special insights on future disruptions
  • Political Impact
  • Economic impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Market Size by Region

• Chart on Market share by geography 2021-2027 (%)
• Data Table on Market share by geography 2021-2027(%)
• North America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • USA
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Canada
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Europe
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Germany
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Spain
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • France
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • UK
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Europe
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Asia Pacific
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • China
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • India
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Japan
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Korea
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Asia Pacific
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Latin America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Brazil
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of South America
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
• Middle East & Africa (MEA)
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • GCC Countries
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Africa
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of MEA
• Exhibit: Chart on Market share 2021-2027 (%)
• Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

• Competitive Landscape
  • Total number of companies covered
• Exhibit: companies covered in the report, 2021
  • Top companies market positioning
• Exhibit: company positioning matrix, 2021
  • Top companies market Share
• Exhibit: Pie chart analysis on company market share, 2021(%)